Exosome Diagnostics and Therapeutics Market Surges, Anticipated to Hit USD 6,848 Million by 2032 | MarketsandMarkets™ [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Yahoo! Finance
million by 2032 at a CAGR of 108.9%. The market is being primarily driven by the emerging potential of exosome-based liquid biopsy, which offers non-invasive options for disease diagnosis, prognosis, and treatment response monitoring across various health conditions. Additionally, significant technological advancements have led to the evolution of biopsy techniques, with liquid biopsies offering several advantages over traditional methods, such as non-invasiveness, reduced procedural costs, and easy disease monitoring. Furthermore, exosomes, known for their stability and ability to carry genetic material such as cellular DNA, mRNA, and miRNA, have gained traction in clinical research as a novel source of biomarkers suitable for diagnostic applications. The market is segmented into exosome diagnostics and exosome therapeutics, with the former accounting for the largest share in 2023. Key contributors to market revenue include products like the ExoDx prostate cancer test, with few oth
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- Declining Stock and Decent Financials: Is The Market Wrong About Bio-Techne Corporation (NASDAQ:TECH)? [Yahoo! Finance]Yahoo! Finance
- Exosomes Development and Manufacturing Market Worth USD 62.8 Billion to 2031- Best Report by InsightAce Analytic Pvt. Ltd. [Yahoo! Finance]Yahoo! Finance
- BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation [Yahoo! Finance]Yahoo! Finance
- BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation [Financial Post (Toronto, Ontario, Canada)]Financial Post
- BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCESPR Newswire
TECH
Earnings
- 5/1/24 - Beat
TECH
Sec Filings
- 5/31/24 - Form SD
- 5/16/24 - Form 4
- 5/14/24 - Form 144
- TECH's page on the SEC website